These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1647061)

  • 21. The preparation of specific sorbents with polyclonal antibodies as a ligand for purification of human antithrombin III.
    Rogalski J; Dawidowicz AL; Wiater A; Gibuła K; Winiarczyk S
    Acta Microbiol Pol; 1998; 47(2):153-65. PubMed ID: 9839374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of antithrombin III concentrate infusion therapy on congenital antithrombin III deficiency].
    Kusumi S; Kobayashi M; Takata N; Imanaka F; Maehama S; Taketomi Y; Fujimura K; Kuramoto A
    Rinsho Ketsueki; 1984 Jan; 25(1):25-30. PubMed ID: 6748254
    [No Abstract]   [Full Text] [Related]  

  • 23. [Separation and purification of antithrombin III, thrombin and carboxypeptidase N using affinity sorption on the copolymer hydroxyalkylmethacrylate with immobilized heparin (heparinoid)].
    Rybák M; Coupek J
    Cesk Farm; 1982 Jan; 31(1):27-9. PubMed ID: 6176339
    [No Abstract]   [Full Text] [Related]  

  • 24. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antithrombin III in plasma free of anti-hemophilic globulin].
    Lepe-Zúñiga JL; Vázquez de Chávez MC; Pizano-López G
    Bol Med Hosp Infant Mex; 1985 Mar; 42(3):159-63. PubMed ID: 3921040
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antithrombin III inhibition of the reaction to thrombin excitation of the anticoagulation system].
    Strukova SM; Umarova BA; Golubeva MG; Dugina TN; Bashkov GV
    Biull Eksp Biol Med; 1987 Mar; 103(3):268-70. PubMed ID: 3828498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of antithrombin III (human).
    Nunez H; Drohan WN
    Semin Hematol; 1991 Jan; 28(1):24-30. PubMed ID: 2017688
    [No Abstract]   [Full Text] [Related]  

  • 29. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Crossed immunoelectrophoresis of congenital antithrombin III (AT) III deficiency, with special reference to the effects of AT III concentrate].
    Matsuo T; Ohoki Y; Kobayashi H; Yamada T
    Rinsho Ketsueki; 1983 Aug; 24(8):1026-31. PubMed ID: 6645071
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
    Kurdowska A; Koj A; Jaśkowska M
    Acta Biochim Pol; 1982; 29(1-2):95-103. PubMed ID: 6983800
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoadsorbent purification of antithrombin: active form and inactive variants.
    Molloy C; Owen MC; Boswell DR
    Thromb Res; 1989 Sep; 55(5):657-60. PubMed ID: 2683194
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
    Biescas H; Gensana M; Fernández J; Ristol P; Massot M; Watson E; Vericat F
    Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pasteurized antithrombin III concentrate for clinical use.
    Smith JK; Winkelman L; Evans DR; Haddon ME; Sims G
    Vox Sang; 1985; 48(6):325-32. PubMed ID: 4013136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus safety of a pasteurized antithrombin III concentrate. Preclinical and clinical data.
    Clemens R; Weidmann E; Merkle W; Bock HL; Mauler R; Hilfenhaus J
    Arzneimittelforschung; 1987 Jul; 37(7):759-62. PubMed ID: 3675669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin III concentrates--are they clinically useful?
    Lechner K; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
    Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
    Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus safety of pasteurized antithrombin III concentrate.
    Roggendorf M; Delvos U; Nováková-Banet A
    Thromb Haemost; 1991 Feb; 65(2):212. PubMed ID: 1647061
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.